Oxford Cancer Analytics
PrivateLast Round
Series A
Jan 9, 2025
Total Funding Raised
$16.46M
Company Overview
Oxford Cancer Analytics is a healthtech company that develops liquid biopsy blood tests using advanced proteomics and artificial intelligence for the early detection of lung cancer and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Government Contracts, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oxford Cancer Analytics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Oxford Cancer Analytics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 9, 2025 | ||||
| Seed | Jan 9, 2023 | ||||
| Seed | Sep 6, 2021 |
Key People
Founding team and executive leadership
Oxford Cancer Analytics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OKG Capital | Series A |
| We Venture Capital | Series A |
| Cancer Research UK | Seed |
| The Francis Crick Institute | Seed |
| Cross Border Impact Ventures | Series A |
| DigitalDx Ventures | Series A |
| LifeArc | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2025
$11M round led by Cross Border Impact Ventures and We Venture Capital.
Oxford Cancer Analytics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oxford Cancer Analytics's valuation, stock price, and market status.